Characteristics of Spiking in Ghent: a Multicentric Prospective Observational Study..
NCT06207396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 107
Last updated 2026-01-07
Summary
This study aims to document the incidence and characteristics of spiking in the Ghent region, both anamnestically and by toxicological analysis.
Spiking will be analyzed by immunoassay testing and high-resolution screening according to the protocol in the laboratory of UZ Gent;
Conditions
- Intoxication
- Unintended Ingestion of Product
Interventions
- DIAGNOSTIC_TEST
-
serum and urine analysis
Spiking will be analyzed by immunoassay testing and high-resolution screening
Sponsors & Collaborators
-
University Hospital, Ghent
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2025-03-31
- Completion
- 2025-05-31
Countries
- Belgium
Study Locations
More Related Trials
-
Drug Interactions With Risk of QT-prolongation in a General Hospital
NCT02043912 ·Status: COMPLETED
-
Naturalistic Study Into the Hangover Effects of MDMA
NCT01400204 ·Status: COMPLETED
-
Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development
NCT01020669 ·Status: COMPLETED
-
Cannabis Cigarettes Used for Doping: Delta-9-Tetrahydrocannabinol (THC) Urine Detection
NCT00534716 ·Status: COMPLETED
-
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
NCT05032833 ·Status: COMPLETED ·Phase: PHASE1
-
Physiological, Behavioral and Subjective Effects of Drugs (GHB)
NCT00058955 ·Status: COMPLETED ·Phase: PHASE1
-
Epidemiology of Acute Self-poisoning in Emergency Services in France
NCT02518386 ·Status: COMPLETED
-
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
NCT05753956 ·Status: COMPLETED ·Phase: PHASE1
-
Psychoactive Drug Uses Among Medical and Pharmacy Students
NCT05115981 ·Status: COMPLETED
-
Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines
NCT00650130 ·Status: COMPLETED
-
Effects of Hallucinogens and Other Drugs on Mood and Performance
NCT02033707 ·Status: COMPLETED ·Phase: PHASE1
-
Trends of Acute Intoxication in Poison Control Centre
NCT05098418 ·Status: UNKNOWN
-
Drug Discrimination in Methadone-Maintained Humans Study 3
NCT01068847 ·Status: COMPLETED ·Phase: PHASE1
-
Quantification of Drugs and Their Degradation Products
NCT01828372 ·Status: UNKNOWN ·Phase: NA
-
Brain Activity Under the Influence of JWH
NCT06044415 ·Status: UNKNOWN ·Phase: NA
-
Marijuana Drug Discrimination and Self-Administration
NCT00943930 ·Status: COMPLETED
-
Benzo[a]Pyrene Ultralow Dose-Response Study
NCT03318978 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
NCT02781519 ·Status: RECRUITING ·Phase: PHASE1
-
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments
NCT07333131 ·Status: RECRUITING
-
Divided Drug Delivery
NCT02869724 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
NCT05698095 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of GH001 in Healthy Volunteers
NCT04640831 ·Status: COMPLETED ·Phase: PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II
NCT02710097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Substance Use Disorder in Chemsex Practice
NCT06476873 ·Status: NOT_YET_RECRUITING ·Phase: NA